1821 – 1840 of 2187
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells.
(
- Contribution to journal › Article
-
Mark
Functional characterization of Factor V-Ile359Thr, a novel mutation associated with thrombosis.
(
- Contribution to journal › Article
-
Mark
Economic evaluation: what are we looking for and how do we get there?
(
- Contribution to journal › Article
-
Mark
Hematopoietic secretory granules as vehicles for the local delivery of cytokines and soluble cytokine receptors at sites of inflammation.
(
- Contribution to journal › Scientific review
-
Mark
Early response predicts thalidomide efficiency in patients with advanced multiple myeloma
(
- Contribution to journal › Article
-
Mark
Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study
(
- Contribution to journal › Article
-
Mark
Overexpression of CXCR4 on human CD34(+) progenitors increases their proliferation, migration, and NOD/SCID repopulation
(
- Contribution to journal › Article
-
Mark
Genetic basis of blood group diversity.
(
- Contribution to journal › Scientific review
-
Mark
A new magnetic resonance imaging scoring method for assessment of haemophilic arthropathy.
(
- Contribution to journal › Article
-
Mark
Targeted disruption of the ribosomal protein S19 gene is lethal prior to implantation
(
- Contribution to journal › Article
-
Mark
A comparative in vitro evaluation of six von Willebrand factor concentrates.
(
- Contribution to journal › Article
-
Mark
Clonogenicity, gene expression and phenotype during neutrophil versus erythroid differentiation of cytokine-stimulated CD34 human marrow cells in vitro.
(
- Contribution to journal › Article
-
Mark
Genetic heterogeneity at the glycosyltransferase loci underlying the GLOB blood group system and collection*.
(
- Contribution to journal › Article
-
Mark
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden.
(
- Contribution to journal › Article
-
Mark
Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions
(
- Contribution to journal › Article
-
Mark
A new hybrid RHCE gene (CeNR) is responsible for expression of a novel antigen
(
- Contribution to journal › Article
-
Mark
Universal red blood cells-enzymatic conversion of blood group A and B antigens.
(
- Contribution to journal › Article
-
Mark
Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.
(
- Contribution to journal › Article
-
Mark
ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience.
(
- Contribution to journal › Article
-
Mark
Anticoagulant factor V and thrombosis risk
(
- Contribution to journal › Debate/Note/Editorial